Automated laboratory solution is catalyst for Lean change
Time savings gained at Leicester Royal Infirmary from sample processing efficiencies

A review of specimen reception and preliminary sample handling using ‘Lean’ principles has led to improvements in the processing of a daily workload of 11,000 samples at the Leicester Royal Infirmary (LRI) Pathology Department.  The sample process step that used to take 4 hours 30 minutes has been reduced to 20 minutes and a previous build up of up to 1000 samples at any given time has been eliminated.  What used to be a difficult-to-manage ‘push’ workflow is now an organised and simple ‘pull’ workflow. 

Crumlin, UK, 27th July 2010

Highly specific monoclonal antibodies available from Randox Life Sciences
Randox Life Sciences is a recognised primary manufacturer of high quality, cost effective monoclonal antibodies to both classic and novel targets. 
 
The complete product range is manufactured at our state of the art facilities in the United Kingdom and are certified to the highest quality standards including ISO13485: 2003, UKAS ILAC G-13:2007 and ISO17025. 

Myconostica announces successful continuation of D round with investment by Medac
19 July 2010

Myconostica Ltd, the UK-based medical diagnostic company developing and commercialising rapid and highly specific tests for life-threatening fungal infections, today announces the completion of an investment by medac Gesellschaft fuer klinische Spezialpraeparate mbH.

Abbott Receives European Regulatory Approval for New Ovarian Cancer Diagnostic Test

Abbott announces CE Mark (Conformité Européene) certification for the ARCHITECT human epididymis protein 4 (HE4) test

Maidenhead, UK, June 16, 2010 — A new diagnostic tool, which studies show can aid in determining the risk of whether a pelvic mass is benign or malignant, is now available in Europe.  This simple blood test is expected to help in the assessment of epithelial ovarian cancer, the most lethal form of gynecological cancer.  This important immunoassay, which will run on Abbott’s ARCHITECT systems, is the first automated HE4 test.

Williams Language Solutions Ltd has taken the commitment to Quality to the next level and is now ISO 9001:2008 certified.
Stefania Williams, MD of Williams Language Solutions, says: “As a Member of BIVDA, it is with great pride that we announce our successful achievement of ISO 9001:2008 certification by LRQA. We truly hope that our commitment to quality is apparent in everything we do. We look forward to assisting BIVDA members with all their translation requirements for the European Markets."

Siemens expands immunoassay range for ADVIA Centaur platform
New assays to offer more comprehensive menu for androgen and prostate testing

Siemens Healthcare Diagnostics has developed a fully automated Sex Hormone Binding Globulin (SHBG) immunoassay for testing plasma or serum samples on the ADVIA Centaur® platform.  A free Prostate Specific Antigen (fPSA) assay for use on the ADVIA Centaur and ADVIA Centaur XP systems is also newly available

Randox provides the Gold Standard in renal damage testing – Cystatin C

Crumlin, UK, 9 July 2010

The Predictive Safety Testing Consortium (PSTC) has provided data which supports the use of various renal markers, including Cystatin C, in a preclinical setting. The biomarkers have been shown to outperform traditional markers, such as creatinine and blood urea nitrogen (BUN), in both specificity and sensitivity. Cystatin C and many other renal damage biomarkers are available from Randox Laboratories.

Landmark deal secures premium pathology services for half a million people in the Maidstone and Tunbridge Wells area

Roche Managed Laboratory Service (MLS) predicted to save Maidstone and Tunbridge Wells NHS Trust at least £2.5million over next 7 years

In a landmark deal with Roche, Maidstone and Tunbridge Wells NHS Trust has opted for a fully automated, Managed Laboratory Service (MLS) solution that will enable them to provide an excellent, patient-focused pathology service, whilst meeting demands for greater cost effectiveness.

Landmark deal secures premium pathology services for half a million people in the Maidstone and Tunbridge Wells area

Roche Managed Laboratory Service (MLS) predicted to save Maidstone and Tunbridge Wells NHS Trust at least £2.5million over next 7 years

In a landmark deal with Roche, Maidstone and Tunbridge Wells NHS Trust has opted for a fully automated, Managed Laboratory Service (MLS) solution that will enable them to provide an excellent, patient-focused pathology service, whilst meeting demands for greater cost effectiveness.

NICE consults on process and methods guides for its Evaluation Pathway Programme for Medical Technologies
The National Institute for Health and Clinical Excellence (NICE) today opens its consultation on the proposed process and methods guides for its Evaluation Pathway Programme for Medical Technologies.  This new area of work was established by NICE in 2009, to focus specifically on the evaluation of innovative medical technologies, including devices and diagnostics.